loadpatents
name:-0.039658784866333
name:-0.014481067657471
name:-0.0138099193573
Kaptein; Allard Patent Filings

Kaptein; Allard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kaptein; Allard.The latest application filed is for "therapeutic combinations of a btk inhibitor, a pi3k inhibitor, a jak-2 inhibitor, and/or a bcl-2 inhibitor".

Company Profile
14.15.41
  • Kaptein; Allard - Zaltbommel NL
  • Kaptein; Allard - Zalthommel NL
  • Kaptein; Allard - Stevenage GB
  • Kaptein; Allard - BH Oss NL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor
App 20220088013 - Hamdy; Ahmed ;   et al.
2022-03-24
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
App 20210346382 - Hamdy; Ahmed ;   et al.
2021-11-11
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor
Grant 11,166,951 - Hamdy , et al. November 9, 2
2021-11-09
Therapeutic combinations of a MEK inhibitor and a BTK inhibitor
Grant 11,154,554 - Rothbaum , et al. October 26, 2
2021-10-26
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate
App 20210322408 - Lannutti; Brian ;   et al.
2021-10-21
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
Grant 11,090,302 - Hamdy , et al. August 17, 2
2021-08-17
Imidazopyrazine inhibitors of Bruton's tyrosine kinase
Grant 10,858,364 - Podoll , et al. December 8, 2
2020-12-08
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor
App 20200069796 - Hamdy; Ahmed ;   et al.
2020-03-05
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
App 20200069668 - Lannutti; Brian ;   et al.
2020-03-05
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
App 20190381044 - Hamdy; Ahmed ;   et al.
2019-12-19
Therapeutic Combinations of an Antifolate and a BTK Inhibitor
App 20190374543 - Kaptein; Allard ;   et al.
2019-12-12
Compositions and Methods for the Assessment of Drug Target Occupancy for Bruton's Tyrosine Kinase
App 20190376971 - Barf; Tjeerd ;   et al.
2019-12-12
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
App 20190374539 - Rothbaum; Wayne ;   et al.
2019-12-12
Therapeutic Combination of a PI3K Inhibitor and a BTK Inhibitor
App 20190358235 - HAMDY; Ahmed ;   et al.
2019-11-28
Imidazopyrazine Inhibitors of Bruton's Tyrosine Kinase
App 20190345164 - Podoll; Terry ;   et al.
2019-11-14
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesi
App 20190314369 - Lannutti; Brian ;   et al.
2019-10-17
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor
App 20190290644 - Hamdy; Ahmed ;   et al.
2019-09-26
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
App 20190209591 - Lannutti; Brian ;   et al.
2019-07-11
Therapeutic combination of PI3K inhibitor and a BTK inhibitor
Grant 10,328,080 - Hamdy , et al.
2019-06-25
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
Grant 10,272,083 - Hamdy , et al.
2019-04-30
Therapeutic Combinations of an Antifolate and a BTK Inhibitor
App 20190008869 - Kaptein; Allard ;   et al.
2019-01-10
Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
App 20190008859 - Rothbaum; Wayne ;   et al.
2019-01-10
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
App 20180369244 - Hamdy; Ahmed ;   et al.
2018-12-27
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor
App 20180250298 - Hamdy; Ahmed ;   et al.
2018-09-06
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK4/6 Inhibitor
App 20180250400 - Hamdy; Ahmed ;   et al.
2018-09-06
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor
App 20180207154 - Hamdy; Ahmed ;   et al.
2018-07-26
Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor
Grant 9,949,971 - Hamdy , et al. April 24, 2
2018-04-24
Therapeutic Combination of PI3K Inhibitor and a BTK Inhibitor
App 20170266191 - Hamdy; Ahmed ;   et al.
2017-09-21
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, a PD-1 Inhibitor, and/or a PD-L1 Inhibitor
App 20170239351 - Hamdy; Ahmed ;   et al.
2017-08-24
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a BCL-2 Inhibitor
App 20170231986 - Hamdy; Ahmed ;   et al.
2017-08-17
BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
App 20170231995 - Hamdy; Ahmed ;   et al.
2017-08-17
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, and/or a CDK 4/6 Inhibitor
App 20170224819 - Hamdy; Ahmed ;   et al.
2017-08-10
BTK Inhibitors
Grant 9,718,828 - De Man , et al. August 1, 2
2017-08-01
Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate
App 20170143712 - Lannutti; Brian ;   et al.
2017-05-25
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor
App 20170136014 - Hamdy; Ahmed ;   et al.
2017-05-18
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor
App 20170095471 - Ahmed; Hamdy ;   et al.
2017-04-06
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
App 20170071962 - Lannutti; Brian ;   et al.
2017-03-16
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
App 20170035881 - Lannutti; Brian ;   et al.
2017-02-09
Btk Inhibitors
App 20170008899 - DE MAN; ADRIANUS PETRUS ANTONIUS ;   et al.
2017-01-12
Mk2 Inhibitors
App 20160159800 - Barf; Tjeerd Andries ;   et al.
2016-06-09
MK2 inhibitors
Grant 9,102,676 - Barf , et al. August 11, 2
2015-08-11
Novel Ligand
App 20150197565 - FARROW; Stuart Neville ;   et al.
2015-07-16
Mk2 Inhibitors
App 20140288109 - BARF; Tjeerd Andries ;   et al.
2014-09-25
Btk Inhibitors
App 20140221333 - De Man; Adrianus Petrus Antonius ;   et al.
2014-08-07
Method for inhibiting binding to B-cell receptor
Grant 8,784,814 - Farrow , et al. July 22, 2
2014-07-22
MK2 inhibitors
Grant 8,772,286 - Barf , et al. July 8, 2
2014-07-08
Method For Inhibiting Binding To B-cell Receptor
App 20140056900 - Farrow; Stuart Neville ;   et al.
2014-02-27
Mk2 Inhibitors
App 20120245175 - Barf; Tjeerd Andries ;   et al.
2012-09-27
Method for inhibiting binding to B-cell receptor
Grant 8,216,576 - Farrow , et al. July 10, 2
2012-07-10
Member of the TNF Ligand Family
App 20090098129 - Farrow; Stuart Neville ;   et al.
2009-04-16
Member of the TNF ligand family
Grant 7,399,593 - Farrow , et al. July 15, 2
2008-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed